VIEW PRESS RELEASE [PDF] Cleveland, OH – August 15, 2011 – Great Lakes NeuroTechnologies’ KinetiSense motion sensor technology will be used in a clinical study to capture and quantify dyskinesias (involuntary, irregular movements) caused by Parkinson’s disease (PD) medication. PD…
Blog Archives
Quantitative Home-Based Monitoring of Parkinson’s Disease Motor Symptoms
D. Heldman, T. Mera, A. Espay, Payne M, J. Giuffrida International Congress of Parkinson’s Disease and Movement Disorders, Toronto, CA 2011
Ergonomic and Human Interface Design Factors for Home-Based Medical devices in Movement Disorders
D. Filipkowski, T. Mera, D. Heldman, J. Giuffrida International Congress of Parkinson’s Disease and Movement Disorders, Toronto, CA 2011
PRESS RELEASE: CLEVEMED ASSISTS AMERICAN MEDICAL ASSOCIATION IN RELEASE OF CPT CODE FOR RECORDING PHYSIOLOGIC TREMOR
VIEW PRESS RELEASE [PDF] CLEVELAND, OHIO (April 25, 2009) – The American Medical Association (AMA) CPT® Editorial Panel approved the release of Category III CPT code 0199T for physiologic recording of tremor using accelerometer(s) and gyroscope(s), (including frequency and amplitude)…
Tagged with: ama, category iii cpt, efficacy, evaluation, kinesia, motor sumptom, movement disorder, symptom severity, telemedicine, tremor, wireless
Clinically Deployable Kinesia Technology for Automated Tremor Assessment
J. Giuffrida, D. Riley, B. Maddux, D. Heldman Mov Disord. 2009 Apr 15;24(5):723-30
PRESS RELEASE: CLEVEMED LAUNCHES CLINICIAL STUDY MONITORING PARKINSON’S DISEASE MOTOR SYMPTOMS IN THE CLINIC AND AT HOME USING KINESIA™
VIEW PRESS RELEASE [PDF] CLEVELAND, Ohio (January 28, 2009) – Cleveland Medical Devices Inc. (CleveMed) has launched a large scale multicenter clinical study to continue development and validation of Kinesia™, a compact wireless system for monitoring severity of Parkinson’s disease…
Tagged with: bradykinesia, clinical study, dyskinesia, kinesia, motion sensor, motor symptoms, parkinson's disease, pd, telemedicine, tremor, validation, wireless
Press Release: CLEVEMED AWARDED $896,000 NIH GRANT TO HELP STROKE PATIENTS RECOVER LOST MOTOR FUNCTION
VIEW PRESS RELEASE [PDF] CLEVELAND, OHIO, October 24, 2006 – Cleveland Medical Devices Inc. (CleveMed) has been awarded a $896,000 Phase II grant from the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH)…